An experimental new medication claims to help people lose weight without muscle loss. Here’s what you need to know about the ...

Ozempic, a GLP-1 receptor agonist, has officially launched in India, offering a new treatment option for type 2 diabetes.

Novo Nordisk’s blockbuster diabetes drug, Ozempic, was officially launched in India on December 12. Unlike in the US and ...

Testing for aldosterone levels may hold the key to treatment-resistant hypertension and many other cardiac conditions, but ...

A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 ...

A research team led by Dr. Àlex Bayés, Head of the Molecular Physiology of the Synapse Group at the Institut de Recerca Sant ...

Ozempic is finally here — but it doesn’t come cheap. With costs touching ₹11,000 a month and generics still a year away, here ...

The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors ...

Scromiting, or cannabis hyperemesis syndrome (CHS), is a rising condition linked to chronic marijuana use, causing severe ...

Multiple teams have used powerful imaging, targeted placebo experiments, and AI to map and understand the brainstem’s pain ...

As flu season peaks, and with several other illnesses going around, here's how to stay safe and healthy this season in ...

A peripherally acting cannabinoid receptor 1 antibody combined with semaglutide induced significant weight loss for adults ...